South Wales, Nov. 7 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "ZYWISPO" on Oct. 20. The details about the trademark application no. UK00004280865 published in the journal no. 2025/044 (Oct. 31).
With Sipara Limited as representative, Bristol-Myers Squibb Company filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004280865
Disclaimer: Curated by HT Syndication.
